tirzepatide or zepbound FDA approval for (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Zepbound® (Tirzepatide) | Mochi Health

This plan is flexible, tailored to each individual and helps prevent unnecessary suffering

The mechanism aligns with decades of research on weight loss and reproductive health: a 2019 study in *Obesity* demonstrated that even modest weight loss (510%) can shift estrogen metabolism and cycle regularity

New research presented this week highlights a link between drugs like Ozempic and a condition known as gastroparesis, so-called stomach paralysis

Note: In February 2026, Novo Nordisk (the manufacturer of Ozempic) announced it had received FDA approval for an oral tablet form of Ozempic as an alternative to Ozempic injections